Category: AtheroMed Inc.Syndicate content

Medtronic-Covidien merger will rival JNJ medical device operations | The week in medtech M&A

June 25, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Seven questions raised by Medtronic's $43B Covidien acquisition; Medtronic, Covidien merger: Good or bad for medtech innovation?; Medtronic, Covidien merger: Mass. Gov. Deval Patrick says he's had no contact with either company; Volcano closes $117M AtheroMed buy; Incubator group buys prostate treatment tech from Endo Health.

Seven questions raised by Medtronic's $43B Covidien acquisition

June 18, 2014 by Brad Perriello

Five take-aways from the Medtronic-Covidien deal

Volcano closes $117M AtheroMed buy

June 18, 2014 by Brad Perriello

Volcano pays nearly $117 million in cash and puts another $15 million on the table in milestones for AtheroMed and its Phoenix atherectomy catheter system.

Volcano closes $117M AtheroMed buy

Volcano (NSDQ:VOLC) said yesterday that it closed the buyout of AtheroMed and its Phoenix atherectomy catheter system, paying out roughly $116.5 million in cash but netting about $1.7 million in cash on hand from AtheroMed.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

M&A: Volcano acquires AtheroMed for $115M

May 27, 2014 by Arezu Sarvestani

Volcano Corp. continues to broaden its peripheral portfolio with the $115 million acquisition of FDA-cleared atherectomy systems maker AtheroMed.

M&A: Volcano acquires AtheroMed and atherectomy system for $115M

Volcano (NSDQ:VOLC) hopes to change its reputation with the $115 million acquisition of privately held AtheroMed and its Phoenix atherectomy catheter system.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

AtheroMed wins 510(k) clearance for atherectomy catheter

January 29, 2014 by Chris Walker

AtheroMed lands 510(k) clearance from the FDA for its Phoenix atherectomy system, used for treating peripheral artery disease.

AtheroMed wins 510(k) clearance for atherectomy catheter

AtheroMed secured 510(k) clearance from the FDA for its Phoenix device, an atherectomy catheter used for treating peripheral artery disease.

The low-profile catheter aims to minimizes vessel interaction and designed to be easy to set up. The Phoenix system features front-cutting technology that cuts while clearing away clearing debris with an internal Archimedes screw, which runs the length of the catheter. The device is available in a variety of sizes, according to a press release.

AtheroMed closes in on $4.5M for PAD treatment

December 13, 2013 by Chris Walker

California-based AtheroMed is just shy of raising $4.5 million through an offering of debt, options, warrants and other securities.

AtheroMed seeks around $5M

AtheroMed is closing in on a $4.5 million fundraising round, offering debt and options offering, SEC documents show.

The Menlo Park, Calif.-based medical device company has so far raised $4.3 million for its operations, according to a regulatory filing.

Stealthy AtheroMed raises $6M for peripheral atherectomy device

April 4, 2013 by Brad Perriello

AtheroMed, which is developing an atherectomy device to treat peripheral artery disease, reports a $6 million funding round.

AtheroMed

AtheroMed said it's raised a $6 million equity round, taking its total funding raise since 2009 to $20 million, according to regulatory filings.

The Menlo Park, Calif.-based medical device company is developing an atherectomy device for treating peripheral artery disease, according to its website.

AtheroMed is still flying under the radar, to judge by the 1-page website, which provides only an email link to contact the company.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp